Covering IPOs, Healthcare and Technology Stocks

Andrei Zakharov

A highly collaborative investment professional and research analyst with 10+ years of international experience in equity research, treasury operations, and trading positions across multiple asset classes at leading multinational banks Citibank and Morgan Stanley, UHNWI-backed family office and European independent equity research firm. A respectable background in equity capital markets, corporate treasury, investment banking operations, equity research analysis and portfolio management.

Shenzhen Dobot IPO (2432.HK): Global Offering, The Rising Star of Collaborative Robotics

Shenzhen Yuejiang Technology IPO: PHIP and Valuation Updates, High Valuations and A Higher TAM

Shenzhen Yuejiang Technology IPO: What’s The IPO Valuation? Long-Term Growth Prospects

Equity Bottom-Up

<ul>
<li>Shenzhen Dobot, a leading manufacturer of collaborative robots in China, has completed its IPO and raised ~HK$680M of the net proceeds in 2024. The IPO was priced at HK$18.80/share.</li>
<li>Shenzhen Dobot shares have massively outperformed year-to-date (+158%) and finished the trading session at HK$62.55 on Monday, up ~233% vs. IPO offer price.</li>
<li>The stock peaked at HK$83.80 in March and fell ~25% over the next two months. The company’s six-month IPO lockup will expire on June 22, 2025.</li>
</ul>


Shenzhen Dobot, a leading manufacturer of collaborative robots in China, has completed its IPO and raised ~HK$680M of the net proceeds in 2024. The IPO was priced at HK$18.80/share.
Shenzhen Dobot shares have massively outperformed year-to-date (+158%) and finished the trading session at HK$62.55 on Monday, up ~233% vs. IPO offer price.
The stock peaked at HK$83.80 in March and fell ~25% over the next two months. The company’s six-month IPO lockup will expire on June 22, 2025.


深セン・ドボット：ロックアップ期限が早期に終了、発行済み株式の約21%が取引可能